3175 results for «367»
3175 results
It's not all about the anatomy - When physiology matters!
14 May 2024 – From EuroPCR 2024
This session, in collaboration with various international cardiology societies, emphasizes the importance of physiology-guided interventions in complex multivessel disease. It presents three cases demonstrating the use of CTCA-derived cFFR, pressure wire assessment in bifurcation PCI, and angio-based FFR to guide treatment decisions. The discussions highlight how...
Management of multiple valve disease
15 May 2024 – From EuroPCR 2024
Antegrade CTO PCI: how to develop a consistent and systematic strategy ?
14 May 2024 – From EuroPCR 2024
This replay provides a comprehensive guide to mastering antegrade wire escalation (AWE), managing failed procedures, and utilizing IVUS to address ambiguous proximal caps. Additionally, learn when to stop in the event of a failed case and explore alternative strategies to ensure optimal patient outcomes.
Intracoronary imaging and complications management
15 May 2024 – From EuroPCR 2024
The big challenge: CTO post-CABG
15 May 2024 – From EuroPCR 2024
TAVI in challenging anatomies
14 May 2024 – From EuroPCR 2024
Explore the complexities of TAVI in patients with intricate aortic stenosis: learn the critical role of detailed CT imaging and meticulous pre-procedural planning, and find out how to customize valve selection and implantation techniques to match unique patient anatomies, such as highly calcified tricuspid valves, low...
PCI: from basics to robots
14 May 2024 – From EuroPCR 2024
This session covers a wide range of topics in percutaneous coronary intervention (PCI), from fundamental aspects to the latest advancements. It includes discussions on non-fasting versus fasting before interventional procedures, radial artery puncture hemostasis, ultrasound-guided transfemoral puncture in complex PCI, the use of uninterrupted direct-acting oral...
How to achieve optimal results in tricuspid valve interventions?
15 May 2024 – From EuroPCR 2024
Hotline: new coronary devices (DES, BRS, DCB)
14 May 2024 – From EuroPCR 2024
This hotline session provides a comprehensive overview of the latest clinical data on new coronary devices, including bioresorbable scaffolds, drug-coated balloons, and drug-eluting stents. Participants will learn about the outcomes of various randomized trials and registry studies, examining the performance of these innovative technologies in different...
Endovascular thrombectomy for pulmonary embolism
14 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on endovascular thrombectomy for pulmonary embolism. It includes cases of pulmonary embolism resistant to systemic thrombolytic therapy, simultaneous acute pulmonary embolism and abdominal aortic aneurysm, paradoxical thrombus in transit with concomitant pulmonary embolism, and the successful...
Cardiovascular intervention for chronic heart failure: where do we stand?
15 May 2024 – From EuroPCR 2024
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial
29 Mar 2025
Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.
Author
Author
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.
Author
